Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-117260
Filing Date
2016-08-08
Accepted
2016-08-08 16:32:39
Documents
75
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v444832_10q.htm 10-Q 572442
2 EXHIBIT 31.1 v444832_ex31-1.htm EX-31.1 9971
3 EXHIBIT 31.2 v444832_ex31-2.htm EX-31.2 9510
4 EXHIBIT 32.1 v444832_ex32-1.htm EX-32.1 4947
  Complete submission text file 0001144204-16-117260.txt   5352766

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20160630.xml EX-101.INS 1220962
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20160630.xsd EX-101.SCH 61365
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20160630_cal.xml EX-101.CAL 49524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20160630_def.xml EX-101.DEF 338425
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20160630_lab.xml EX-101.LAB 428121
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20160630_pre.xml EX-101.PRE 386588
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 161814603
SIC: 2834 Pharmaceutical Preparations